Following the success and approval of tirzepatide (Mounjaro, Eli Lilly, Indianapolis, IN, USA) in 2022 by FDA for treatment of T2DM, the SURMOUNT programme investigated its use as an anti-obesity medication in those without diabetes
Joseph Brewer evaluated 112 patients with a prior diagnosis of ME/CFS
Contains all the essential B vitamins, B1 ,B2,B3,B5 ,B6 Benefits: Energy Production Red Blood Cell Formation Metabolic Support Stress Support Promotes metabolic balance and cardiovascular health Reduce Weakness &Fatigue VITAMIN D3 Injection Immune support, mood regulation, and bone health in one essential shot
Available studies conducted predominantly on animal models indicate that 5-amino-1MQ is orally active in rats